Like DecisionView, Inc.

closed 4/24/2012 via BusinessWire

IMS Health Incorporated, acquired DecisionView, Inc.

synopsis: IMS Health has acquired DecisionView, a software solutions company that helps life sciences organizations plan and track patient enrollment for clinical trials around the world. DecisionView offers its clients an innovative suite of decision support tools to improve the speed, efficiency and performance of clinical trial planning and management.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the leading provider of information services for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, analytics, and consulting platforms to help clients better understand the value of medicines. "
target parent: Granite Ventures, LLC
target: DecisionView, Inc.
DecisionView develops web-based software solutions that enable life sciences organizations around the world to improve clinical trial performance. Its flagship solution, StudyOptimizer®, is a web-based solution that helps clinical trial organizations plan, forecast and track patient enrollment.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/30/2021 via BNC Analysis

CSAM Health AS, acquired MedSciNet

synopsis: CSAM Health Group AS, the leading provider of niche eHealth solutions in the Nordics, announced that they have acquired MedSciNet AB, a provider of benchmark eHealth solutions within clinical research.
buyer: CSAM Health AS (OB:CSAM:$30.36)
CSAM is a leading Norwegian company in the specialized eHealth market with a unique blend of best in class innovative technology, and outstanding human skills. Their diverse portfolio of software solutions enables healthcare providers to access relevant clinical information at the point of care. "
target: MedSciNet
MedSciNet is a Stockholm based company specialising in design and development of web applications and on-line database systems for clinical trials and studies, quality registries, medical bio-banks, and other solutions within the medical field.
price ($mm)
$2.88
rev ($mm)
$2
EBITDA ($mm)
EV / rev
1.7x
EV / EBITDA
announced 5/27/2021 via PR Newswire

Thoma Bravo, LLC, will acquire Greenphire, Inc

synopsis: Thoma Bravo, a leading private equity investment firm focused on the software and technology-enabled services sector, has reached an agreement to acquire Greenphire, the global leader in financial lifecycle management software for clinical trials, from The Riverside Company.
buyer: Thoma Bravo, LLC
Thoma Bravo is a leading private equity firm focused on the software and technology-enabled services sectors. Thoma Bravo partners with a company’s management team to implement operating best practices, invest in growth initiatives and make acquisitions intended to accelerate revenue and earnings. "
target parent: The Riverside Company
target: Greenphire, Inc
Greenphire is the leader in global clinical trial financial process automation. Greenphire's best-in-class solutions optimize clinical trial performance by streamlining payment and logistical workflows from sponsors and CROs to sites and patients.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/19/2021 via GlobeNewswire

Scarritt Group Inc., acquired TrialTech Medical Inc.

synopsis: Scarritt Group Inc., a technology-enabled leader in the planning and execution of meetings for Investigators and Coordinators of clinical trials, has acquired TrialTech Medical Inc, a leader in the application of cloud- based software and artificial intelligence enabled digital marketing for the recruitment of eligible subjects for clinical trials.
buyer: Scarritt Group Inc.
Scarritt Group is a technology-enabled, full service meeting planning and logistics company specializing in delivering clinical trial meetings worldwide. "
target: TrialTech Medical Inc.
TrialTech Medical is a software and services company supporting the pharmaceutical, biotechnology and medical device industries. They work in coordination with their clients' medical and clinical operations teams to optimize the process of clinical trial planning, recruitment and enrollment.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/20/2019 via BNC Analysis

Monterro, acquired Viedoc

synopsis: Monterro, the leading B2B software investor in the Nordics, has acquired a majority stake in Viedoc, a modern and sophisticated electronic data capture (EDC) system. Viedoc enables researchers to gather and evaluate clinical trial data more efficiently.
buyer: Monterro
Sweden-based Monterro is the leading B2B software investor in the Nordics, with a mission to turn software companies into market leaders. With operational experience from successfully developing and running companies, Monterro actively supports its portfolio companies in all aspects of growth. "
target: Viedoc
Viedoc is a modern and sophisticated electronic data capture (EDC) system. Viedoc enables researchers to gather and evaluate clinical trial data more efficiently. Their powerful EDC system has been used in over 2000 trials in more than 75 countries in all therapeutic areas and clinical phases.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/24/2019 via BNC Analysis

TrialScope, acquired Clinical Trial Connect, LLC

synopsis: TrialScope has acquired Clinical Trial Connect, a platform used by disease foundations and advocacy groups that connects their community members to relevant clinical trials. As part of the acquisition, founder Mike Wenger will share his technological expertise as part of the TrialScope team.
buyer: TrialScope
TrialScope is the global leader in clinical trial transparency and compliance. TrialScope's tools and systems enable their customers to improve their clinical trial process, mitigate registry and lifecycle risk, and ultimately achieve greater business success. "
target: Clinical Trial Connect, LLC
Clinical Trial Connect is a platform used by disease foundations and advocacy groups that connects their community members to relevant clinical trials. Clinical Trial Connect was founded by Mike Wenger, who developed his own algorithm for matching patients to clinical trials.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/28/2019 via BNC Analysis

JLL Partners, Water Street Healthcare Partners, acquired THREAD Research

synopsis: Water Street Healthcare Partners and JLL Partners have acquired Orange County, California-based THREAD, a provider of technology that enables virtual research approaches to modernize clinical studies and registries.
buyer: JLL Partners
buyer: Water Street Healthcare Partners
JLL Partners is a middle-market private equity firm with a 30-year track record of building and transforming businesses. Water Street is a strategic investor focused exclusively on healthcare. The firm has a strong record of building market-leading companies across key growth sectors in healthcare. "
target: THREAD Research
THREAD is a virtual research platform used by biopharma, CROs, non-profit researchers, and life science organizations to capture global clinical study data in between, as well as during and instead of clinic visits.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/17/2019 via GlobeNewswire

Anju Software, will acquire OmniComm Systems, Inc.

synopsis: Anju Software, a leading provider of comprehensive software solutions to the life sciences industry, will be acquiring OmniComm, a healthcare technology company that provides web-based electronic data capture and eClinical solutions and related value-added services.
buyer parent: ABRY Partners, LLC
buyer: Anju Software
Anju Software, Inc. is a leading provider of comprehensive software solutions to the life sciences industry that provides an integrated platform spanning clinical operations, medical affairs, and commercial divisions, including integrated data intelligence. "
target: OmniComm Systems, Inc. (OTCPK:OMCM:$14,891.70)
OmniComm is a healthcare technology company that provides web-based electronic data capture and eClinical solutions and related value-added services to pharmaceutical and biotech companies, contract research organizations, and other clinical trial sponsors.
price ($mm)[EV]
$72 [$81]
rev ($mm)
$25
EBITDA ($mm)
$2
EV / rev
3.4x
EV / EBITDA
46.2x
announced 6/12/2019 via BusinessWire

Dassault Systemes, will acquire Medidata

synopsis: Dassault Systèmes, a provider of solutions that transform the way products are designed, provided and supported, will be acquiring Medidata, a provider of a platform for clinical development, commercial, and real-world data.
buyer: Dassault Systemes (ENXTPA:DSY:$5,323.17)
Based in France, Dassault Systèmes provides clients with virtual universes to imagine sustainable innovations. Its solutions transform the way products are designed, produced, and supported. They foster social innovation, expanding possibilities for the virtual world to improve the real world. "
target: Medidata (MDSO:$660.00)
Medidata is leading the digital transformation of life science, with a platform for clinical development, commercial, and real-world data. Powered by artificial intelligence, Medidata helps accelerate value, minimize risk and optimize outcomes.
price ($mm)[EV]
$5,825 [$5,822]
rev ($mm)
$660
EBITDA ($mm)
$81
EV / rev
8.8x
EV / EBITDA
72.2x
closed 4/10/2019 via BNC Analysis

TriNetX, acquired Custodix N.V.

synopsis: TriNetX has acquired Custodix, a Belgian-based provider of clinical trial patient recruitment solutions. TriNetX is a global health research network that has revolutionised clinical research. Custodix is a provider of clinical trial patient recruitment solutions offering a range of solutions for ensuring compliance.
buyer: TriNetX
TriNetX is the global health research network enabling healthcare organizations, biopharma and CROs to collaborate, enhance trial design, accelerate recruitment and bring new therapies to market faster. "
target: Custodix N.V.
Custodix is a Belgian provider of clinical trial patient recruitment solutions offering a range of solutions for ensuring compliance with European and US data protection legislation and security best practices.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/17/2018 via Company Press Release

Oracle Corporation, will acquire GoBalto

synopsis: Oracle announced that it has entered into an agreement to acquire goBalto, which delivers leading cloud solutions to accelerate clinical trials by streamlining and automating the selection and set up of the best performing clinical research sites to conduct trials.
buyer: Oracle Corporation (ORCL:$39,766.00)
Oracle is a computer technology corporation developing and marketing computer hardware systems and enterprise software products. By eliminating complexity and simplifying IT, Oracle enables its customers to accelerate innovation and create added value for their customers. "
target: GoBalto
goBalto, Inc. is an award winning, venture backed group of industry veterans that creates simple, focused software for the global drug trial industry. Its products offer drug trial sponsors and clinical research organizations the fastest, easiest possible way to start clinical studies on the web.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/21/2018 via BusinessWire

Anju Software, acquired Sylogent

synopsis: Anju Software Inc., a life sciences software platform backed by Providence Equity Partners, has acquired Sylogent. Sylogent delivers cloud based state of the art software solutions and business services to the pharmaceutical industry focused specifically on the information required to bring a product to market.
buyer parent: Providence Equity Partners Inc.
buyer: Anju Software
Anju Software is a life sciences enterprise software platform focused on delivering exceptional business application solutions. Anju was founded by professionals with deep software domain expertise and a track record of building software platforms through strategic acquisitions and organic growth. "
target: Sylogent
Sylogent delivers software and business services to the pharmaceutical industry focused specifically on the information required to bring a product to market. They ensure the timely completion of critical information, maximize compliance goals and reduce risk management liability.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/9/2017 via Company Press Release

PRA Health Sciences, acquired Parallel 6

synopsis: HCAP Partners, a California-based mezzanine debt and private equity firm, announced that it has exited its investment in Parallel 6, Inc. (“P6”), a mobile clinical (“mClinical”) SaaS platform designed to recruit, enroll, engage and manage patients in clinical trials. P6 was sold to PRA Health Sciences, Inc.
buyer parent: Kohlberg Kravis Roberts & Co.
buyer: PRA Health Sciences (PRAH:$1,698.48)
PRA Health Sciences, Inc. is one of the world’s leading global CROs by revenue, providing outsourced clinical development services to the biotechnology and pharmaceutical industries. Since 2000, PRA has participated in approximately 3,500 clinical trials worldwide. "
target parent: HCAP Partners
target: Parallel 6
Parallel 6’s technology digitally enrolls, engages and manages patients using mobile endpoints. Sponsors and clinical research organizations can connect directly with and manage patients anywhere in the world, seamlessly integrating into their daily lives.
price ($mm)
$40
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/16/2016 via BNC Analysis

DrugDev, acquired SecureConsent

synopsis: DrugDev has acquired SecureConsent, a developer of mobile e-consent software. SecureConsent replaces the paper methods that have historically been used to secure informed consent from patients participating in drug studies with an e-consent method that uses tablets and other mobile devices.
buyer: DrugDev
DrugDev streamlines engagement among sponsors, CROs and doctors to advance the common goal of doing more trials. Through the creation of global, standardized processes DrugDev is consistently and efficiently transforming the way drug developers identify, engage and pay investigators. "
target: SecureConsent
The software products developed by Secure Consent replace the paper methods that have historically been used to secure informed consent from patients participating in drug studies with an e-consent method that uses tablets and other mobile devices.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/19/2016 via PR Newswire

BioClinica, Inc., acquired Clinverse, Inc.

synopsis: Bioclinica, Inc., a specialty trials services and technology provider, announced it has acquired Clinverse, Inc. Clinverse automates and manages the entire financial lifecycle of global clinical trials for contract research organizations and pharmaceutical companies. Its suite of products pays clinical trial sites, vendors and their subjects.
buyer: BioClinica, Inc.
Bioclinica is a specialty services provider that utilizes expertise and technology to create clarity in the clinical trial process. Bioclinica is organized into three business segments to deliver focused service and multifaceted technologies. "
target: Clinverse, Inc.
Clinverse, Inc. architected the industry's first automated financial management technology solution for clinical trials. Their solution standardizes clinical trial financial management for millions of financial transactions across the globe, including clinical site payments.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/17/2015 via PR Web

Aris Global LLC, acquired Medsight Solutions Inc.

synopsis: ArisGlobal®, a leading provider of Cloud solutions to life sciences companies, is pleased to announce that it has acquired Medsight Solutions, including the revolutionary integrated risk management solution, Medsight Sapphire (now known as ArisGlobal agBalance™).
buyer: Aris Global LLC
For more than 20 years, ArisGlobal has led in the development of innovative software solutions for pharmacovigilance & safety, regulatory affairs, clinical research and medical information. "
target: Medsight Solutions Inc.
Medsight Solutions Inc. is a life sciences solutions and professional services company with specialties in Clinical trial optimization, Benefit-risk assessment and Compliance monitoring.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/3/2014 via PR Newswire

PAREXEL International Corporation, acquired ClinIntel Ltd.

synopsis: PAREXEL International Corporation, a global clinical research organization, announced that the Company has acquired all of the outstanding equity securities of privately-owned ClinIntel, a provider of clinical Randomization and Trial Supply Management (RTSM) services, based in the United Kingdom.
buyer: PAREXEL International Corporation (PRXL:$1,939.36)
PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, and medical communications services to the worldwide pharmaceutical, biotechnology and medical device industries. "
target: ClinIntel Ltd.
Headquartered in the United Kingdom, ClinIntel is a provider of clinical Randomization and Trial Supply Management (RTSM) services. The company was founded in 2009, and works with biopharmaceutical companies and contract research organizations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/24/2014 via PR Newswire

The WIRB-Copernicus Group, acquired ePharmaSolutions, Inc.

synopsis: WIRB-Copernicus Group (WCG), the world's largest provider of regulatory and ethical review services for clinical research, announced that ePharmaSolutions (ePS) has joined its group of companies. ePharmaSolutions is a leading provider of eClinical solutions and technology-enabled services that improve the conduct of clinical trials.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is the world's largest provider of regulatory and ethical solutions for clinical research, including Institutional Review Board (IRB) and Institutional Biosafety Committee (IBC) review. "
target: ePharmaSolutions, Inc.
ePharmaSolutions is a leading provider of eClinical solutions and specialty clinical services that help improve the way trial sites are selected, trained, activated and managed to exceed enrollment goals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/16/2014 via PR Newswire

BioClinica, Inc., acquired Blueprint Clinical

synopsis: BioClinica®, Inc., a leading provider of eClinical Solutions for the Pharmaceutical Industry, has announced the acquisition of Blueprint Clinical, a fast-growing company offering ground-breaking technology and extensive expertise to drive successful Risk-Based Monitoring (RBM) strategies for clinical trials.
buyer parent: JLL Partners
buyer: BioClinica, Inc.
BioClinica, Inc. is a leading global provider of integrated clinical trial management technologies including eClinical solutions for clinical trial supply management, forecasting and optimization, electronic data capture, randomization, and clinical trial management. "
target: Blueprint Clinical
Blueprint Clinical, Inc. creates Software-as-a-Service tools that help improve monitoring of clinical trials. Their first product, Blueprint Clinical Compass™, ultimately allows risk based monitoring implementation thereby improving quality and efficiency of clinical trials.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/29/2012 via Market Wire

Oracle Corporation, will acquire ClearTrial, LLC.

synopsis: Oracle announced that it has entered into an agreement to acquire ClearTrial, a leading provider of cloud-based Clinical Trial Operations (CTO) applications that make the planning, sourcing, and tracking of clinical projects and financial performance faster and more accurate.
buyer: Oracle Corporation (ORCL:$39,766.00)
Oracle Corporation is the world's largest enterprise software company. The company is a leading provider of systems software, including database management, application development, and application server software. "
target: ClearTrial, LLC.
ClearTrial, LLC provides software-as-a-service based Clinical Trial Operations software for planning, forecasting, and tracking clinical project and financial performance. The company serves biopharmaceutical companies, CROs, medical device companies, and small biotechs worldwide.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/24/2012 via BusinessWire

IMS Health Incorporated, acquired DecisionView, Inc.

synopsis: IMS Health has acquired DecisionView, a software solutions company that helps life sciences organizations plan and track patient enrollment for clinical trials around the world. DecisionView offers its clients an innovative suite of decision support tools to improve the speed, efficiency and performance of clinical trial planning and management.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the leading provider of information services for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, analytics, and consulting platforms to help clients better understand the value of medicines. "
target parent: Granite Ventures, LLC
target: DecisionView, Inc.
DecisionView develops web-based software solutions that enable life sciences organizations around the world to improve clinical trial performance. Its flagship solution, StudyOptimizer®, is a web-based solution that helps clinical trial organizations plan, forecast and track patient enrollment.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/13/2019 via BNC Analysis

IQVIA, acquired Linguamatics Limited

synopsis: Health analytics and contract research heavyweight IQvia has acquired bioinformatics company Linguamatics. Linguamatics delivers market-leading Natural Language Processing (NLP) based AI solutions for high-value knowledge discovery and decision support from text.
buyer: IQVIA (NYSE:IQV:$10,412.00)
IQVIA Holdings Inc. provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services. "
target: Linguamatics Limited
Linguamatics delivers market-leading Natural Language Processing (NLP) based AI solutions for high-value knowledge discovery and decision support from text. They empower their customers to speed up drug development and improve patient outcomes.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/17/2017 via BusinessWire

eMids Technologies, acquired Encore Health Resources

synopsis: emids, a rapidly growing global provider of IT services and solutions for the healthcare and life sciences industries, announced the acquisition of Encore Health Resources, a leading healthcare information analytics company focused on value-based care and electronic health records for providers.
buyer: eMids Technologies
emids is a premier provider of healthcare IT services and solutions. emids enables healthcare entities to achieve accessible, affordable and high-quality care by providing custom application and data solutions. "
target parent: QuintilesIMS
target: Encore Health Resources
Encore Health Resources is a leading healthcare information analytics company focused on value-based care and electronic health records for providers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/25/2016 via BusinessWire

IMS Health Incorporated, acquired Privacy Analytics

synopsis: IMS Health has acquired Privacy Analytics Incorporated. Privacy Analytics offers an innovative suite of data governance software and advisory services that enable stakeholders to optimize benefits of the growing volume and availability of new, complex datasets while protecting patient privacy.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. IMS Health uses anonymous healthcare data to deliver critical, real-world disease and treatment insights. "
target: Privacy Analytics
Privacy Analytics enables healthcare organizations to quickly and easily apply a risk-based responsible de-identification methodology that ensures individual privacy and legal compliance. They offer expert training, software, methodology and services that protect the privacy of individuals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/3/2016 via BusinessWire

Quintiles Transnational Corp. merged with IMS Health Incorporated,

synopsis: Quintiles IMS Holdings, Inc. announced that it has successfully completed its merger of equals transaction between IMS Health Holdings, Inc. and Quintiles Transnational Holdings Inc. The merger creates a leading information and tech-enabled global healthcare service provider, and a full suite of end-to-end clinical and commercial offerings.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. They connect configurable SaaS applications to complex healthcare data in the IMS One™ cloud platform. "
target: Quintiles Transnational Corp. (Q:$4,497.17)
Quintiles is the world’s largest provider of biopharmaceutical development services and commercial outsourcing services. They help customers navigate the increasingly complex healthcare environment to improve efficiency and to deliver better healthcare outcomes.
price ($mm)
$8,750
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/4/2016 via BusinessWire

IMS Health Incorporated, acquired Dimensions Healthcare, LLC

synopsis: IMS Health, a leading global provider of information and technology services to the healthcare and life sciences industries, announced completion of its acquisition of Dimensions Healthcare, a United Arab Emirates (UAE) company which provides high quality healthcare systems to payers, providers and regulatory bodies.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. They connect configurable SaaS applications to complex healthcare data in the IMS One™ cloud platform. "
target: Dimensions Healthcare, LLC
Dimensions Healthcare (“Dimensions”) is a leading developer of healthcare informatics solutions that assist private and public sectors to offer higher-quality healthcare services by collecting and processing information that is used to decrease inefficiencies and reduce wasteful expenditures.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/3/2016 via PR Newswire

IMS Health Incorporated, acquired AlphaImpactRx, Inc

synopsis: Symphony Technology Group announced the closing of the sale of AlphaImpactRx, a leading provider of primary research and analytics-based insight for biopharmaceutical and consumer health companies to IMS Health, a global information and technology services company serving the healthcare industry.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. They connect configurable SaaS applications to complex healthcare data in the IMS One™ cloud platform. "
target parent: Symphony Technology Group
target: AlphaImpactRx, Inc
AlphaImpactRx is the leading provider of primary research-based insights, analytics and solutions to pharmaceutical, consumer health and medical device companies. They provide market research to help its global healthcare clients make informed and business decisions to market their products.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/9/2015 via BNC Analysis

IMS Health Incorporated, acquired IASIST, S.A.

synopsis: IMS Health, a leading global information and technology services company, has acquired IASIST, an added value, professional service company which offers health care providers, payers and the health industry the clinical and economic information required to improve quality and efficiency in their organizations.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is an information and technology services company providing clients in the healthcare industry with solutions to measure and improve their performance. The company's IMS One™ cloud platform provides comprehensive insights into diseases, treatments, costs and outcomes. "
target: IASIST, S.A.
Iasist is an added value, professional service company which offers health care providers, payers and the health industry the clinical and economic information required to improve quality and efficiency in their organisations and the services provided to their customers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/6/2015 via BusinessWire

IMS Health Incorporated, acquired Dataline Software

synopsis: IMS Health has acquired Dataline Software, a leader in Big Data analytics for healthcare. U.K.-based Dataline has worked closely with life sciences companies, payers, healthcare authorities and academia to deliver tailored software for rapid analysis and elegant visualizations of large, complex healthcare data sets.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is an information and technology services company providing clients in the healthcare industry with solutions to measure and improve their performance. The company's IMS One™ cloud platform provides comprehensive insights into diseases, treatments, costs and outcomes. "
target: Dataline Software
Dataline is a software solutions company specializing in big-data analytics solutions for healthcare. They also provide consultancy, training, system implementation, application development and technical support to a wide and varied client base.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/1/2015 via BusinessWire

IMS Health Incorporated, purchased CRM and Strategic Data Division from Cegedim

synopsis: IMS Health, a leading global provider of information and technology services to the healthcare and life sciences industries, completed its acquisition of certain customer relationship management (CRM) and strategic data businesses of Cegedim, a global technology and services company specializing in healthcare.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with comprehensive solutions to measure and improve their performance. The company connects complex healthcare data on diseases, treatments, costs and outcomes. "
seller: Cegedim (ENXTPA:CGM:$592.02)
Cegedim is a global technology and services company specializing in healthcare. Cegedim’s CRM solutions help Life Sciences and Healthcare clients in 80 countries drive sales effectiveness, optimize marketing programs across multiple channels and mitigate regulatory compliance risks.
price ($mm)
$523
rev ($mm)
$584
EBITDA ($mm)
$88
EV / rev
0.9x
EV / EBITDA
5.9x
closed 5/8/2014 via BusinessWire

IMS Health Incorporated, acquired Forcea

synopsis: IMS Health has acquired Forcea, a leading Belgium-based provider of business intelligence applications and analytics, to advance performance management capabilities for hospitals and life sciences organizations around the globe.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading worldwide provider of information, technology, and services dedicated to making healthcare perform better. The IMS global technology infrastructure, advanced analytics and proprietary software platforms help clients improve patient outcomes and operate more efficiently. "
target: Forcea
Forcea is a leading Belgium-based provider of business intelligence applications and analytics, to advance performance management capabilities for hospitals and life sciences organizations around the globe.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/9/2013 via BusinessWire

IMS Health Incorporated, acquired Pygargus

synopsis: IMS Health, a leading worldwide provider of information, technology and services, has acquired Pygargus, an industry-leading life sciences advisory and analytics firm based in Sweden, to further advance its technology-enabled Real-World Evidence solutions and global RWE footprint.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading worldwide provider of information, technology, and services dedicated to making healthcare perform better. The IMS global technology infrastructure, advanced analytics and proprietary software platforms help clients improve patient outcomes and operate more efficiently. "
target: Pygargus
Pygargus is a leading independent Scandinavian life science consultancy specialized in Real World Outcomes Research, offering expertise in electronic medical records, registry data handling, data integration and scientific project management.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/15/2013 via BNC Analysis

IMS Health Incorporated, will acquire Diversinet Corp.

synopsis: Toronto-based mobile health company Diversinet agreed to sell its assets to subsidiaries of Parsippany, New Jersey-based IMS Health for about $3.5 million. The sale includes Diversinet’s intellectual property, software, and customer contracts. IMS Health is a leading worldwide provider of healthcare information, technology, and services.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading worldwide provider of information, technology, and services dedicated to making healthcare perform better. The IMS global technology infrastructure, advanced analytics and proprietary software platforms help clients improve patient outcomes and operate more efficiently. "
target: Diversinet Corp. (US:DVNTF:$1.51)
Diversinet provides its customers and partners with ultra-secure, patented mobile technologies and connected health solutions. Its core multilingual publishing platform supports rapid deployment of secure and HIPAA-compliant Web-to-mobile applications.
price ($mm)
$1.75
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/6/2013 via BusinessWire

IMS Health Incorporated, acquired Incential Software, Inc.

synopsis: IMS Health has acquired Incential Software, an industry-leading Software-as-a-Service company based in Raleigh, NC, to advance its sales performance management capabilities for life sciences organizations worldwide. Incential delivers technology & services that integrate incentive compensation, data management, & business intelligence applications.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading worldwide provider of information, technology, and services dedicated to making healthcare perform better. The IMS global technology infrastructure, advanced analytics and proprietary software platforms help clients improve patient outcomes and operate more efficiently. "
target: Incential Software, Inc.
Incential Software is a leading provider of sales performance management software and services to pharmaceutical, biotech and medical device companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/20/2013 via BusinessWire

IMS Health Incorporated, acquired 360 Vantage

synopsis: IMS Health announced the acquisition of 360 Vantage, a leading provider of cloud-based multi-channel CRM and closed loop marketing technologies, to further extend its commercial Software-as-a-Service capabilities for life sciences and healthcare organizations around the globe.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading worldwide provider of information, technology, and services dedicated to making healthcare perform better. The IMS global technology infrastructure, advanced analytics and proprietary software platforms help clients improve patient outcomes and operate more efficiently. "
target: 360 Vantage
Established in 2005 and headquartered in Chandler, Arizona, 360 Vantage is a leader in cloud-based mobile sales and marketing systems designed to solve the more complex front office challenges in Life Sciences and Healthcare.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/30/2013 via BusinessWire

IMS Health Incorporated, acquired Semantelli

synopsis: IMS Health announced the acquisition of Semantelli Corporation, a Bridgewater, N.J.-based social media analytics company, to extend its marketing and consumer engagement capabilities for healthcare organizations around the world. Semantelli offers cloud-based tools that automate the collection of healthcare-specific social media content.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading worldwide provider of information, technology, and services dedicated to making healthcare perform better. The IMS global technology infrastructure, advanced analytics and proprietary software platforms help clients improve patient outcomes and operate more efficiently. "
target: Semantelli
Semantelli’s solutions for global life sciences and healthcare companies address compliance needs in social media, guide marketing activities and identify new real-time opportunities with insights gleaned from social media.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/12/2013 via Yahoo, Inc.

IMS Health Incorporated, acquired Appature

synopsis: IMS Health has acquired Appature, a leading Software-as-a-Service (SaaS) company based in Seattle. Appature offers clients a cloud-based relationship marketing platform to address the complexities of today’s multi-stakeholder healthcare environment, and to enable the measurement and optimization of relationship marketing programs across channels.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the leading provider of information services for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, analytics, and consulting platforms to help clients better understand the value of medicines. "
target parent: Ignition Partners
target: Appature
Appature is a Seattle-based technology company that provides cloud-based marketing solutions designed exclusively for healthcare companies. Leaders in the pharmaceutical, medical device, and health and wellness industries rely on Appature to realize the true potential of their marketing efforts
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/15/2012 via BusinessWire

IMS Health Incorporated, acquired TTC LLC

synopsis: IMS Health has acquired TTC, a Philadelphia-based benchmarking solutions and analytics company that helps life sciences organizations around the world plan for and negotiate the costs of clinical trials. TTC offers clients a robust set of clinical trial cost benchmarks, budgeting and negotiation tools.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the leading provider of information services for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, analytics, and consulting platforms to help clients better understand the value of medicines. "
target: TTC LLC
TTC is the leader in global clinical trial cost benchmarking. With offices in Philadelphia, TTC has a proven track record in all aspects of outsourcing cost management, from the budgeting of protocols and clinical trials to negotiations with clinical sites and other providers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/14/2012 via BusinessWire

IMS Health Incorporated, acquired PharmaDeals Ltd.

synopsis: IMS Health announced the acquisition of PharmaDeals Ltd., a market-leading provider of online information about business transactions, licensing, and mergers & acquisitions activity within the global pharmaceutical industry. PharmaDeals maintains a web-based subscription database containing more than 46,000 records of industry transactions.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the leading provider of information services for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, analytics, and consulting platforms to help clients better understand the value of medicines. "
target parent: PharmaVentures Ltd.
target: PharmaDeals Ltd.
PharmaDeals Ltd. is a market-leading provider of online information about business transactions, licensing, and mergers & acquisitions activity within the global pharmaceutical industry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/24/2012 via BusinessWire

IMS Health Incorporated, acquired DecisionView, Inc.

synopsis: IMS Health has acquired DecisionView, a software solutions company that helps life sciences organizations plan and track patient enrollment for clinical trials around the world. DecisionView offers its clients an innovative suite of decision support tools to improve the speed, efficiency and performance of clinical trial planning and management.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the leading provider of information services for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, analytics, and consulting platforms to help clients better understand the value of medicines. "
target parent: Granite Ventures, LLC
target: DecisionView, Inc.
DecisionView develops web-based software solutions that enable life sciences organizations around the world to improve clinical trial performance. Its flagship solution, StudyOptimizer®, is a web-based solution that helps clinical trial organizations plan, forecast and track patient enrollment.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/24/2012 via BusinessWire

IMS Health Incorporated, acquired PharmARC Analytic Solutions Pvt. Ltd.

synopsis: IMS Health has acquired PharmARC, an India-based company specializing in commercial analytics and services for the life sciences industry. The acquisition adds significant scale to a world-class services delivery platform, strengthens IMS’s business process outsourcing capabilities.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the leading provider of information services for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, analytics, and consulting platforms to help clients better understand the value of medicines. "
target: PharmARC Analytic Solutions Pvt. Ltd.
PharmARC is a leading provider of analytic solutions for the efficient commercialization of drugs and medical products. The firm’s analytics and services enable its life sciences customers to make informed decisions related to their sales and marketing strategies and implementation.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/5/2010 via Company Press Release

CPP Investment Board, TPG Capital, acquired IMS Health Incorporated

synopsis: IMS Health, the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, announced the completion of its acquisition by entities created by certain affiliates of TPG Capital, L.P. (“TPG”) and the CPP Investment Board (“CPPIB”).
buyer: CPP Investment Board
buyer: TPG Capital
TPG is a leading global private investment firm with approximately $45 billion of capital under management across a family of funds. TPG's investment philosophy has been to create value by investing in change - change created by industry trends, economic cycles or specific company circumstances. "
target: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries. IMS offers leading-edge market intelligence products and services that are integral to clients’ day-to-day operations.
price ($mm)[EV]
$4,014 [$5,057]
rev ($mm)
$2,171
EBITDA ($mm)
$489
EV / rev
2.3x
EV / EBITDA
10.4x
announced 7/7/2008 via PR Newswire

Signalife, Inc., will acquire Heart One Global Research

synopsis: Signalife, Inc. and Heart One Global Research, an Irish-based heart information and clinical information management concern -- with technology used across the world through subsidiaries and affiliates in eight different countries have agreed to merge or consummate a similar business combination making them one company.
buyer: Signalife, Inc. (SGN:$0.00)
Signalife, Inc. is a life sciences company focused on the monitoring, detection and prevention of disease through continuous biomedical signal monitoring. "
target: Heart One Global Research
Heart One Global is the London-based international developer and distributor of information technologies that are clinically focused, mature, stable, robust, comprehensive, flexible, portable, and standards-based electronic health record solutions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/20/2007 via BusinessWire

Elsevier Business Information, acquired Clinical Practice Model Resource Center, Inc.

synopsis: Elsevier, the world's leading publisher of science and health information, has purchased CPM Resource Center from Eclipsys, a leading provider of integrated enterprise clinical, revenue cycle, access management, and decision support solutions. CPM Resource Center is a leading provider of executable evidence-based clinical tools.
buyer parent: Reed Elsevier plc
buyer: Elsevier Business Information
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier’s 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year. "
target parent: Eclipsys Corporation
target: Clinical Practice Model Resource Center, Inc.
CPM Resource Center’s evidence-based products and professional services assist healthcare organizations in creating a healthy work culture and interdisciplinary integration using a professional practice framework and standardization.
price ($mm)
$25
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/19/2007 via BusinessWire

Healthnostics, Inc., acquired MedNets, Inc.

synopsis: Healthnostics, Inc. a medical and biotechnology analytics company, today announced the completion of the MedNets.com acquisition, an Internet portal providing healthcare information resources to consumers and professionals.
buyer: Healthnostics, Inc. (OTCPK:HNSS:$0.20)
Healthnostics, Inc. is a medical and biotechnology analytics company that provides patient clinical monitoring and risk management systems to acute care hospitals, and utilizes its Internet portals to deliver medical and biotechnology resource information. "
target: MedNets, Inc.
MedNets, Inc. offers MedExplore, our medical professional and patient Healthcare Information Directory, through our web site. We have gathered over 20,000 healthcare links in our directory, creating the source to the finest medical information on the Internet.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/26/2007 via PR Newswire

ConnectivHealth, acquired Relegent

synopsis: ConnectivHealth today announced it has acquired Relegent, a Nashville, Tenn.--based provider of health care information to the hospital and education industries. Terms of the deal were not disclosed.
buyer parent: Chrysalis Ventures
buyer: ConnectivHealth
ConnectivHealth is building a network of health care information and new media businesses that enable the delivery, distribution, and organization of important health information for physicians, health care professionals, hospitals, and consumers. "
target: Relegent
Relegent is a leading health care information and marketing firm based in Nashville. Relegent owns and operates HealthTeacher, the leading K-12 online health curriculum. The company also exclusively markets Discovery Hospital content to hospitals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/18/2007 via BusinessWire

MCF Corporation, acquired MedPanel, Inc.

synopsis: MCF Corporation has completed the acquisition of MedPanel, Inc., an online medical market intelligence firm. With the closing of the transaction, MedPanel, Inc. becomes Panel Intelligence, LLC, a wholly owned subsidiary of MCF Corporation.
buyer: MCF Corporation (MEM:$0.00)
MCF Corporation is a financial services holding company that provides investment research, capital markets services, corporate and venture services, investment banking, asset management and wealth management through its operating subsidiaries. "
target: MedPanel, Inc.
MedPanel provides online medical market intelligence to the life sciences industry through custom research and syndicated studies. Research services include study design, recruitment, programming, panel moderation, advanced data analysis and summaries.
price ($mm)
$7.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/16/2006 via PR Newswire

Medstat, acquired Solucient LLC

synopsis: The Thomson Corporation, a leading provider of information to professional customers worldwide, has completed the acquisition of Solucient, LLC, a healthcare information business. Terms of the deal were not disclosed.
buyer parent: The Thomson Corporation
buyer: Medstat
Thomson Medstat provides healthcare information services – databases, software applications, analytic consulting, and research services – to all sectors of the healthcare industry. "
target parent: The Nielsen Company, Inc.
target: Solucient LLC
Solucient is an information products company serving the healthcare industry. It is a leader in providing tools and vital insights that healthcare managers use to improve the performance of their organizations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/19/2006 via Company Press Release

Reed Elsevier plc, acquired Gold Standard Multimedia

synopsis: Elsevier, a world-leading healthcare and scientific publisher, announced today that it has entered into a definitive agreement to acquire the entire share capital of Gold Standard, Inc., a US-based developer of online clinical drug information products, services and solutions to the healthcare market.
buyer: Reed Elsevier plc (LSE:REL:$9,933.91)
Reed Elsevier is a world leading publisher and information provider. Operating in the scientific, medical, legal, risk and business-to-business sectors, Reed Elsevier provides high value and flexible information solutions to professional end users, with increasing emphasis on internet delivery. "
target: Gold Standard Multimedia
A privately-held company founded in 1993, Tampa, Florida-based Gold Standard Multimedia (GSM) is a leading developer of innovative medical education and drug information software, online services and e-learning solutions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/20/2005 via BNC Analysis

EBSCO Publishing, Inc., acquired DynaMed, LLC

synopsis: Expanding its presence in the medical arena, EBSCO Publishing (http://www.ebsco.com) announced the acquisition of DynaMed (http://www.dynamicmedical.com), an evidence-based clinical reference tool developed by a physician.
buyer parent: EBSCO Industries, Inc.
buyer: EBSCO Publishing, Inc.
EBSCO Publishing is the world's premier database aggregator, offering a suite of nearly 300 full-text and secondary research databases. EBSCO serves the content needs of all researchers: Academic, Medical, K-12, Public Library, Corporate, Government. "
target: DynaMed, LLC
DynaMed is a point-of-care reference resource designed to provide doctors and medical researchers with the best available evidence to support clinical decision-making.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/14/2005 via PR Newswire

National Care Network, Inc., acquired Data Advantage Corporation

synopsis: National Care Network (NCN) has completed the acquisition of Data Advantage Corporation, a leading healthcare information company. The acquisition combines NCN's recognized cost control services with Data Advantage's strategic products and information.
buyer: National Care Network, Inc.
NCN is a privately owned healthcare cost management firm established in 1994 by medical claims experts. NCN is an industry leader in providing highly effective cost control services to all types of medical claims payors across the United States. NCN's proactive approach of on-going two way communica"
target: Data Advantage Corporation
Data Advantage Corporation is a healthcare information company. The company specializes in providing the healthcare, business and financial community a cost effective source for reliable and timely healthcare information products and services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
cancelled 11/17/2005 via BusinessWire

VNU nv, cancelled an acquisition of IMS Health Incorporated

synopsis: VNU NV announced it has agreed with IMS Health, Inc. to terminate the planned merger of the two companies. VNU said the two companies decided to call off their merger after shareholders claiming to represent nearly 50% of VNU's outstanding shares said they would not support the transaction under any circumstances.
buyer parent: Valcon Acquisition BV
buyer: VNU nv (NLSN:$6,311.00)
The Nielsen Company is world’s leading provider of marketing information, audience measurement, and business media products and services. Nielsen provides clients with the most complete view of their consumers and their markets. "
target: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries. IMS offers leading-edge market intelligence products and services that are integral to clients’ day-to-day operations.
price ($mm)
$7,000
rev ($mm)
$1,569
EBITDA ($mm)
$517
EV / rev
4.5x
EV / EBITDA
13.5x
closed 3/14/2018 via PR Newswire

BioInformatics Inc., acquired IMV Ltd.

synopsis: BioInformatics Inc., the leading market research firm supporting the analytical instrumentation and life science industries, and owner of The Science Advisory Board, has acquired IMV Publishing, a recognized leader in market research and online publishing for the medical imaging and clinical diagnostic instruments markets.
buyer: BioInformatics Inc.
BioInformatics Inc. is the leading research and advisory firm serving the life science, diagnostic and analytical instrument industries. Their expertise includes assessing the size and attractiveness of markets, optimizing product configurations and pricing and validating corporate acquisitions. "
target: IMV Ltd.
IMV Publishing is a recognized leader in market research and online publishing for the medical imaging and clinical diagnostic instruments markets. IMV’s complete line of research reports provides decision makers with site-specific databases and comprehensive market reports.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/4/2010 via Market Wire

TransUnion LLC, acquired MedData

synopsis: TransUnion announced it acquired MedData LLC. The Charlotte-based company provides healthcare insurance information and data solutions for hospitals, physician practices and major healthcare insurance companies. Financial terms of the deal were not disclosed.
buyer: TransUnion LLC (TRU:$2,696.90)
TransUnion is a global leader in credit and information management. The company creates advantages for millions of people around the world by gathering, analyzing and delivering information. For businesses TransUnion delivers comprehensive data and advanced analytics. "
target parent: AGData
target: MedData
MedData is the healthcare division of AGDATA, L.P. MedData was formed to apply and use state-of-the-art database and real-time transaction processing technology for the healthcare industry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/7/2013 via PR Newswire

Wolters Kluwer Health, acquired Health Language Inc.

synopsis: Wolters Kluwer Health, a leading provider of information and business intelligence for professionals, students and institutions in medicine, nursing, allied health and pharmacy, announced that it has completed the acquisition of Health Language, Inc., a leader in the fast-growing Medical Terminology Management (MTM) market.
buyer parent: Wolters Kluwer NV
buyer: Wolters Kluwer Health
Wolters Kluwer Health is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Its customers include professionals, institutions and students in medicine, nursing, allied health and pharmacy. "
target: Health Language Inc.
Health Language, Inc. specializes in the development, delivery and marketing of software that reduces the complexity of incorporating medical vocabulary and coding standards into healthcare information technology (HCIT) applications.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/14/2008 via BusinessWire

Health Grades, Inc., acquired Adviware Pty. Ltd.

synopsis: Health Grades, Inc., the leading healthcare ratings company, announces the acquisition of WrongDiagnosis.com, a highly trafficked health information and community Web site. WrongDiagnosis.com was owned by Adviware Pty. Ltd., a privately held company based in Australia.
buyer: Health Grades, Inc. (HGRD:$58.17)
Health Grades, Inc. is the leading healthcare ratings organization, providing ratings and profiles of hospitals, nursing homes and physicians. Millions of patients and many of the nation’s largest employers, health plans and hospitals rely on HealthGrades’ independent ratings and advisory services. "
target: Adviware Pty. Ltd.
Adviware Pty. Ltd owns and operats WrongDiagnosis.com,which includes symptoms, diagnosis and treatment information including a database of statistics and cross-referenced medical information, tools and community forums covering more than 11,000 conditions and treatments.
price ($mm)[EV]
$6.24 [$4.41]
rev ($mm)
$2
EBITDA ($mm)
$1
EV / rev
3.9x
EV / EBITDA
7.2x
closed 4/11/2006 via PR Newswire

Workplace Options, acquired HelpHorizons.com, Inc.

synopsis: Workplace Options, the largest provider of work-life employee benefits in America, today announced the acquisition of HelpHorizons.com, Inc., the country's leading provider of practice management and connectivity solutions for mental health professionals and behavioral health organizations.
buyer: Workplace Options
Workplace Options (WPO) is America's largest provider of work-life services and software that help EAPs and other third-parties run their business more profitably and efficiently. "
target: HelpHorizons.com, Inc.
Dedicated to providing innovative services and information to consumers and mental health professionals. We offer the largest mental health professional referral database online today and technology that supports secure, private e-counseling via e-mail, chat rooms, or videoconferencing.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/17/2013 via PR Web

Healthcare Data Solutions, acquired StratCenter

synopsis: Healthcare Data Solutions, a leading provider of healthcare databases, compliance and business intelligence services, announced the acquisition of StratCenter®, an established leader, delivering the most comprehensive provider facility databases and sales solutions available to the supply chain.
buyer: Healthcare Data Solutions
Healthcare Data Solutions is a leading healthcare information services company focused on building and maintaining the most accurate, compliance-grade data on Physicians, Dentists, Nurse Practitioners and other Healthcare Providers, as well as Pharmacies and Hospitals. "
target: StratCenter
StratCenter was founded in 2002 to provide the healthcare industry with a single point of access to the latest industry news, and to the most comprehensive sets of public and privately-held data on hospitals, IDNs, GPOs, and provider groups.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 2/3/2021 via Company Press Release

Edgewood Partners Insurance Center, Inc., will acquire Pharmaceutical Strategies Group, LLC

synopsis: EPIC announced that it has agreed to acquire Pharmaceutical Strategies Group (PSG). The move incorporates the expertise and resources of the nation’s largest independent pharmacy benefit consulting firm into the EPIC Employee Benefits Consulting practice.
buyer: Edgewood Partners Insurance Center, Inc.
Edgewood Partners Insurance Center, Inc. (EPIC) is an innovative retail property & casualty and employee benefits insurance brokerage and consulting firm, headquartered in San Francisco. EPIC Brokers has a nationwide presence with a depth of industry expertise across key lines of insurance. "
target parent: Blue Wolf Capital Management, LLC.
target: Pharmaceutical Strategies Group, LLC
Pharmaceutical Strategies Group (PSG) advocates for clients as they navigate the challenges of drug cost management. PSG’s innovative consulting and technology solutions, including its data and analytics platform Artemetrx, deliver actionable insights with exceptional financial and clinical value.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/27/2020 via BusinessWire

Teleperformance SA, will acquire Health Advocate, Inc

synopsis: Teleperformance, a leading global group in digitally integrated business services, is to acquire Health Advocate from Intrado Corporation, a global leader in technology-enabled services and portfolio company of funds managed by affiliates of Apollo Global Management, Inc. Health Advocate, Inc. offers healthcare advocacy and assistance services.
buyer: Teleperformance SA (ENXTPA:TEP:$6,450.89)
Teleperformance is the worldwide leader in outsourced omnichannel customer experience management. They connect brands with their customers by providing customer care, technical support, customer acquisition, digital solutions, analytics, back-office and other specialized services. "
target parent: Apollo Global Management
target: Health Advocate, Inc
Health Advocate, Inc. offers healthcare advocacy and assistance services. The company provides claims denials, healthcare bills, payment arrangements, and physicians, hospitals, and healthcare provider advisory and consulting services.
price ($mm)
$690
rev ($mm)
$140
EBITDA ($mm)
$50
EV / rev
4.9x
EV / EBITDA
13.8x
closed 1/8/2020 via BusinessWire

Press Ganey Associates, Inc., acquired Strategic Management Decisions

synopsis: Press Ganey has announced its acquisition of Strategic Management Decisions (SMD), a leading health care HR consulting and predictive analytics company. SMD’s proprietary technology enables health systems to optimize their talent acquisition and talent management efforts and realize measurable improvements in key HR performance metrics.
buyer: Press Ganey Associates, Inc. (PGND:$344.32)
Press Ganey offers an integrated suite of solutions that enables enterprise transformation across the patient journey. Delivered through a cutting-edge digital platform, Press Ganey solutions address safety, clinical excellence, patient experience, and workforce engagement. "
target: Strategic Management Decisions
Strategic Management Decisions (SMD) is a leading health care HR consulting and predictive analytics company. SMD’s proprietary technology enables health systems to optimize their talent acquisition and talent management efforts and realize measurable improvements in key HR performance metrics.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like DecisionView, Inc.


read more

DecisionView, Inc.

MedSciNet

Greenphire, Inc

TrialTech Medical Inc.

Viedoc

Clinical Trial Connect, LLC

THREAD Research

OmniComm Systems, Inc.

Medidata

Custodix N.V.

GoBalto

Sylogent

Parallel 6

SecureConsent

Clinverse, Inc.

Medsight Solutions Inc.

ClinIntel Ltd.

ePharmaSolutions, Inc.

Blueprint Clinical

ClearTrial, LLC.

read more

DecisionView, Inc.

read more

Linguamatics Limited

Encore Health Resources

Privacy Analytics

Quintiles Transnational Corp.

Dimensions Healthcare, LLC

AlphaImpactRx, Inc

IASIST, S.A.

Dataline Software

Cegedim

Forcea

Pygargus

Diversinet Corp.

Incential Software, Inc.

360 Vantage

Semantelli

Appature

TTC LLC

PharmaDeals Ltd.

DecisionView, Inc.

PharmARC Analytic Solutions Pvt. Ltd.

read more

IMS Health Incorporated

Heart One Global Research

Clinical Practice Model Resource Center, Inc.

MedNets, Inc.

Relegent

MedPanel, Inc.

Solucient LLC

Gold Standard Multimedia

DynaMed, LLC

Data Advantage Corporation

IMS Health Incorporated

IMV Ltd.

MedData

Health Language Inc.

Adviware Pty. Ltd.

HelpHorizons.com, Inc.

StratCenter

Pharmaceutical Strategies Group, LLC

Health Advocate, Inc

Strategic Management Decisions

Geography
Matching Companies
Ticker: CHNG
 
 
 
 
 
 
 
 
Change Healthcare Corporation
Change Healthcare Corporation
Change Healthcare is a leading independent healthcare technology company that provides data and analytics-driven solutions to improve clinical, financial and patient engagement outcomes in the U.S. healthcare system.
year
2020
rev ($mm)
$1,646.91
EBITDA ($mm)
EBIT ($mm)
($155.95)
Net Income ($mm)
Employees
15000
  • drill down
  • watch
Ticker: TRHC
 
 
 
 
 
 
 
 
Tabula Rasa Healthcare
Tabula Rasa Healthcare
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk.
year
2018
rev ($mm)
$204.27
EBITDA ($mm)
$16.27
EBIT ($mm)
$1.63
Net Income ($mm)
Employees
952
  • drill down
  • watch
Ticker: ZMD
 
 
 
 
 
 
 
 
ZoomMed Inc.
ZoomMed Inc.
Zoommed Inc. develops and markets various computer applications for healthcare professionals in Canada. The company builds and operates the ZoomMed Communication Network, a clinical interoperable information exchange network between physicians and various other stakeholders of the healthcare sector.
year
2014
rev ($mm)
$6.08
EBITDA ($mm)
$2.65
EBIT ($mm)
$2.78
Net Income ($mm)
Employees
40
  • drill down
  • watch
Ticker: ASX:MDR
 
 
 
 
 
 
 
 
MedAdvisor Limited
MedAdvisor Limited
MedAdvisor is a world class medication management platform focused on addressing the gap and burden of medication adherence. The highly automated Australian software system connects patients to their local pharmacy, providing them with real time access to their personal medication records.
year
2016
rev ($mm)
$1.05
EBITDA ($mm)
($2.13)
EBIT ($mm)
($2.15)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: AIM:INS
 
 
 
 
 
 
 
 
Instem
Instem
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide.
year
2020
rev ($mm)
$38.71
EBITDA ($mm)
$6.69
EBIT ($mm)
$5.66
Net Income ($mm)
$0.47
Employees
268
  • drill down
  • watch
Ticker: SYPT
 
 
 
 
 
 
 
 
Scrypt, Inc.
Scrypt, Inc.
Since 1998, Austin-based Scrypt, Inc. has been creating elegant document productivity tools for healthcare that eliminate manual processes and paper to save time and money. Scrypt has more than 30,000 customers across all 50 states.
year
2009
rev ($mm)
$0.27
EBITDA ($mm)
($0.85)
EBIT ($mm)
($0.91)
Net Income ($mm)
Employees
7
  • drill down
  • watch
Ticker: DATA
 
 
 
 
 
 
 
 
DATATRAK International, Inc.
DATATRAK International, Inc.
DATATRAK International, Inc. is a worldwide ASP for the EDC industry. The Company provides a suite of software products supporting the use of DATATRAK EDC(TM) and related services to the pharmaceutical, biotechnology, and medical device industries.
year
2012
rev ($mm)
$9.72
EBITDA ($mm)
($1.37)
EBIT ($mm)
($1.53)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: NYSE:IQV
 
 
 
 
 
 
 
 
IQVIA
IQVIA
IQVIA Holdings Inc. provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services.
year
2018
rev ($mm)
$10,412.00
EBITDA ($mm)
$1,950.00
EBIT ($mm)
$809.00
Net Income ($mm)
$259.00
Employees
58000
  • drill down
  • watch
Ticker: TSE:2413
 
 
 
 
 
 
 
 
M3, Inc.
M3 Inc. represents the three Ms of Medicine, Media, and Metamorphosis. Their company was founded with the goal of changing the world of medicine through making full use of the power of the Internet.
year
2019
rev ($mm)
$1,127.03
EBITDA ($mm)
$319.84
EBIT ($mm)
$286.78
Net Income ($mm)
$193.56
Employees
6024
  • drill down
  • watch
Ticker: TSE:4483
 
 
 
 
 
 
 
 
JMDC Inc.
JMDC Inc.
JMDC Inc. offers information services. The Company provides medical data statistics, life insurance data statistics, health data platform management, and other services. JMDC provides its services throughout Japan.
year
2019
rev ($mm)
$91.75
EBITDA ($mm)
EBIT ($mm)
$13.68
Net Income ($mm)
$9.40
Employees
441
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
Clarivate Analytics
Clarivate Analytics
Clarivate Analytics is a research analytics software company that provides subscription-based services in research and patent analytics. Organizations and researchers rely on the knowledge bases from Clarivate for information about pharmaceutical and biotech intelligence and IP management.
year
2021
rev ($mm)
$1,441.88
EBITDA ($mm)
$460.43
EBIT ($mm)
$77.06
Net Income ($mm)
Employees
8568
  • drill down
  • watch
Ticker: ENXTPA:CGM
 
 
 
 
 
 
 
 
Cegedim
Cegedim
Founded in 1969, Cegedim is a global technology and services company specializing in the healthcare field. Cegedim supplies services, technological tools, specialized software, data flow management services and databases.
year
2020
rev ($mm)
$592.02
EBITDA ($mm)
$54.63
EBIT ($mm)
$53.83
Net Income ($mm)
$12.91
Employees
5171
  • drill down
  • watch
Ticker: PBSV
 
 
 
 
 
 
 
 
Pharma-Bio Serv Inc.
PharmaBio Serv offers a full range of Regulatory Compliance Quality Systems, Validation & Qualification Services and Technology Transfer based on the latest FDA guidelines, as well as day to day process support.
year
2008
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: OTCPK:MDCL
 
 
 
 
 
 
 
 
Medicine Man Technologies, Inc.
Medicine Man Technologies, Inc.
Medicine Man Technologies, Inc. was established in March 2014. They have provided guidance for several clients that have successfully secured licenses to operate cannabis businesses within their state.
year
2016
rev ($mm)
$0.82
EBITDA ($mm)
($0.18)
EBIT ($mm)
($0.20)
Net Income ($mm)
Employees
4
  • drill down
  • watch
Ticker: OTCPK:NBGV
 
 
 
 
 
 
 
 
NewBridge Global Ventures, Inc.
NewBridge Global Ventures, Inc.
NewBridge Global Ventures, Inc. is a US public company which provides business consulting services to companies operating within the legal medical cannabis and hemp related industries.
year
2017
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
($4.16)
Net Income ($mm)
Employees
14
  • drill down
  • watch
Ticker: LSE:UDG
 
 
 
 
 
 
 
 
UDG Healthcare plc
UDG Healthcare plc
UDG Healthcare plc specialises in supply chain, packaging, medical, regulatory, and sales and marketing services. They provide innovative, outsourced services that deliver outstanding results for healthcare companies and enable them to bring their products quickly to market.
year
2019
rev ($mm)
$1,298.52
EBITDA ($mm)
$178.30
EBIT ($mm)
$122.78
Net Income ($mm)
$57.45
Employees
7790
  • drill down
  • watch
Ticker: PDII
 
 
 
 
 
 
 
 
PDI, Inc.
PDI, Inc.
PDI is a leading healthcare commercialization company providing go-to-market strategy and execution to established and emerging pharmaceutical, biotechnology, diagnostics and healthcare companies in the United States.
year
2015
rev ($mm)
$140.12
EBITDA ($mm)
($14.89)
EBIT ($mm)
($19.53)
Net Income ($mm)
Employees
952
  • drill down
  • watch
Ticker: CNSX:TCAN
 
 
 
 
 
 
 
 
TransCanna
TransCanna
TransCanna specializes in assisting cannabis farmers and manufacturers get recognized by end consumers who in turn purchase their products. They offer our services throughout every aspect of the ecosystem; from branding and design, to transportation and distribution, to marketing and sales.
year
2017
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
($1.66)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: TSE:6095
 
 
 
 
 
 
 
 
MedPeer,Inc.
MedPeer,Inc.
MedPeer provides appropriate services at every stage of the clinical process physicians are involved in day-to-day clinical operation. Drug Evaluation provides detailed peer reviews of prescription drugs, and Meet the Experts allows members to consult expert physicians in specific therapeutic areas.
year
2016
rev ($mm)
$9.13
EBITDA ($mm)
$0.94
EBIT ($mm)
$0.39
Net Income ($mm)
$0.20
Employees
44
  • drill down
  • watch
Ticker: TDOC
 
 
 
 
 
 
 
 
TelaDoc, Inc.
TelaDoc, Inc.
Teladoc is the nation’s first and largest telehealth provider with more than 6 million members nationwide. Teladoc enhances access to affordable, high-quality medical care for adults and children via videoconferencing or telephone consultations.
year
2020
rev ($mm)
$716.29
EBITDA ($mm)
($8.58)
EBIT ($mm)
($53.74)
Net Income ($mm)
Employees
2727
  • drill down
  • watch
Ticker: AIM:MED
 
 
 
 
 
 
 
 
MedaPhor
MedaPhor
MedaPhor is a global provider of advanced ultrasound training simulators for medical professionals. Founded in 2004, they have headquarters in Cardiff, UK and San Diego, USA, and our customers are some of the world's leading medical institutions.
year
2017
rev ($mm)
$5.48
EBITDA ($mm)
($2.09)
EBIT ($mm)
($2.82)
Net Income ($mm)
Employees
31
  • drill down
  • watch